Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Syphilitic retinitis is inflammation of the retina caused by syphilis infection (Treponema pallidum). It is part of ocular syphilis and can occur at any stage of infection. Retinal involvement can reduce vision and can mimic other retinal diseases. Prompt diagnosis and antibiotic treatment are important because delayed care can lead to lasting damage.
read more about syphilitic retinitis ...Syphilitic retinitis results from systemic syphilis reaching the eye through the bloodstream. Risk is higher with untreated infection and in people with HIV, though ocular syphilis can occur without HIV. The eye findings can appear weeks to years after initial infection, depending on disease stage. Because syphilis can also involve the nervous system, ocular involvement is often managed using neurosyphilis treatment regimens. Medical history, exposure risk, and systemic symptoms help guide clinical suspicion.
Symptoms often include blurred vision, new floaters, and reduced contrast. Eye redness, light sensitivity, and aching discomfort can also occur, especially when uveitis is present. Vision changes can involve one eye or both eyes, and severity can vary widely. Some people notice distortion or a central blurry spot when the macula is affected. Sudden vision decline should be evaluated quickly because several retinal infections can worsen fast.
Diagnosis starts with a dilated eye exam, often paired with OCT and fluorescein angiography to document retinal and choroidal involvement. Blood tests usually include a nontreponemal test (RPR or VDRL) plus a treponemal-specific test to confirm infection. Because ocular disease can overlap with neurosyphilis, a clinician may recommend additional neurologic assessment, which can include cerebrospinal fluid testing in selected cases. HIV testing is commonly recommended because co-infection can change risk and follow-up needs. Close follow-up after treatment helps confirm that inflammation is improving.
Treatment is systemic antibiotic therapy, most often intravenous penicillin G using regimens recommended for neurosyphilis and ocular syphilis. When penicillin allergy exists, an infectious disease clinician guides safe alternatives or desensitization when appropriate. Anti-inflammatory drops or oral steroids can be used in selected cases, typically after antibiotics begin, based on the clinical picture. Partner notification and systemic evaluation are part of care because syphilis is a sexually transmitted infection. Repeat eye exams and imaging track recovery and check for relapse.
Syphilitic retinitis itself is not spread from one eye to another person. The underlying syphilis infection is contagious through sexual contact and from pregnancy to fetus in congenital cases. Medical evaluation and treatment are important for public health and for eye outcomes.
Often, yes. Prompt antibiotic treatment can reduce inflammation and improve vision, especially when treatment starts early. Some vision loss can persist if retinal tissue has been damaged. Follow-up imaging helps confirm response.
Yes. Untreated ocular syphilis can damage the retina and optic nerve and can lead to lasting vision loss. Early recognition and treatment improve the odds of better recovery. Any new vision change with known or suspected syphilis needs urgent care.
Syphilis - STI Treatment Guidelines. Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/syphilis.htm. Date Accessed February 4, 2026.
Ophthalmologic Manifestations of Syphilis. EyeWiki. https://eyewiki.org/Ophthalmologic_Manifestations_of_Syphilis. Date Accessed February 4, 2026.
Ocular Syphilis: A Reemerging Threat. American Academy of Ophthalmology (EyeNet). https://www.aao.org/eyenet/article/ocular-syphilis-reemerging-threat. Date Accessed February 4, 2026.
Ocular Syphilis. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK532938/. Date Accessed February 4, 2026.
Acute syphilitic posterior placoid chorioretinitis: clinical features and treatment outcomes. PubMed. https://pubmed.ncbi.nlm.nih.gov/29735755/. Date Accessed February 4, 2026.